A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Fig 2
Cervista® HPV test, cytology and PCR HPV genotype analysis.
HPV titre is indicated by the height of the bar graph above the cut off with the Y axis representing the fold over zero (FOZ) ratio of sample or control divided by the no target control signal. The cytology status is indicated by colour and shading with the HPV type shown above the bar. (A) Represents the results before treatment with lopinavir; (B) Represents results after 4 and (C) 12 weeks after treatment.